BOLD Boundless Bio, Inc. - Common Stock
$2,90
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 7, 2026
Rango 52S
$1–$3
96% of range
Calificación del Analista
HOLD
6 analysts
Precio Objetivo
$4
+38% upside
P/E (TTM)
-1.1
ROE
-46.7%
Margen de Beneficio Neto
—
Acerca de Boundless Bio, Inc. - Common Stock Descripción general de la empresa de Wikipedia
BOLD Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.90
Capitalización Bursátil
$65M
P/E (TTM)
-1.1
BPA (TTM)
$-2.60
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-46.7%
Deuda/Capital
—
Rango 52S
$1 – $3
BOLD Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-2.60
2023-12-31
→
2025-12-31
Flujo de caja libre
$-47M
2024-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BOLD
Mediana de Pares
P/E (TTM)
-1.1
—
P/B (P/C)
0.7
1.6
Price / FCF (Precio / FCF)
-1.4
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BOLD
Mediana de Pares
ROA
-32.0%
-64.3%
ROE
-46.7%
-102.1%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BOLD
Mediana de Pares
Current Ratio (Ratio corriente)
8.7
4.8
Quick Ratio (Ratio Rápido)
8.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BOLD
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BOLD
Mediana de Pares
BOLD Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
VENTA
6 analistas
- Compra fuerte 0 0,0%
- Compra 0 0,0%
- Mantener 3 50,0%
- Venta 1 16,7%
- Venta fuerte 2 33,3%
Precio objetivo a 12 meses
1 analistas · 2026-08-19
Mín
$4.00
Máx
$4.00
Objetivo mediano
$4.00
+38,2%
Objetivo medio
$4.00
+38,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-1.06 | $-0.59 | -0.47% |
| 31 de marzo de 2026 | $-0.60 | $-0.59 | -0.01% |
| 31 de diciembre de 2025 | $-0.58 | $-0.53 | -0.05% |
| 30 de septiembre de 2025 | $-0.62 | $-0.59 | -0.03% |
| 30 de junio de 2025 | $-0.70 | $-0.66 | -0.04% |
| 31 de marzo de 2025 | $-0.71 | $-0.75 | 0.04% |
| 31 de diciembre de 2024 | $-0.74 | $-0.78 | 0.04% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| XBIT | — | -1.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $45M | $55M | $43M | |
| SG&A Expense | $19M | $18M | $12M | |
| Operating Expenses | $64M | $73M | $55M | |
| Operating Income | $-64M | $-73M | $-55M | |
| Interest Income | $5M | $8M | $5M | |
| Other Non-op | $-2.0K | $12.0K | $80.0K | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-58M | $-65M | $-49M | |
| EPS (Basic) | $-2.60 | $-3.85 | $-40.65 | |
| EPS (Diluted) | $-2.60 | $-3.85 | $-40.65 | |
| Shares (Basic) | 22,360,000 | 16,984,000 | 1,216,000 | |
| Shares (Diluted) | 22,360,000 | 16,984,000 | 1,216,000 | |
| EBITDA | $-62M | $-72M | · |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $18M | $27M | $24M | |
| Short-term Investments | $90M | $126M | $97M | |
| Prepaid Expense | $2M | $2M | $3M | |
| Current Assets | $110M | $154M | $124M | |
| PP&E (Net) | $3M | $4M | $3M | |
| PP&E (Gross) | $8M | $8M | $5M | |
| Accum. Depreciation | $5M | $4M | $3M | |
| Total Assets | $157M | $206M | $130M | |
| Accounts Payable | $1M | $1M | $2M | |
| Current Liabilities | $13M | $8M | $9M | |
| Capital Leases | $46M | $48M | · | |
| Total Liabilities | $58M | $56M | $9M | |
| Common Stock | $2.0K | $2.0K | $0 | |
| Paid-in Capital | $358M | $352M | $9M | |
| Retained Earnings | $-260M | $-201M | $-136M | |
| AOCI | $64.0K | $121.0K | $40.0K | |
| Stockholders' Equity | $99M | $151M | $-127M | |
| Liabilities + Equity | $157M | $206M | $130M | |
| Shares Outstanding | 22,407,000 | 22,300,000 | 1,248 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $1M | $957.0K | |
| Stock-based Comp | $6M | $8M | $3M | |
| Deferred Tax | $0 | · | · | |
| Other Non-cash | $4M | $-4M | · | |
| Operating Cash Flow | $-47M | $-61M | $-47M | |
| CapEx | $546.0K | $3M | $633.0K | |
| Investing Cash Flow | $38M | $-26M | $-38M | |
| Financing Cash Flow | $141.0K | $90M | $98M | |
| Net Change in Cash | $-9M | $3M | $13M | |
| Free Cash Flow | $-47M | $-63M | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -32.0% | -38.9% | · | |
| ROE | -46.7% | -554.9% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 8.7 | 19.0 | · | |
| Quick Ratio | 8.6 | 18.7 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-58M | $-65M | · | |
| Market Cap | $27M | $64.7K | · | |
| P/E | -0.5 | -0.8 | · | |
| P/B | 0.3 | 0.0 | · | |
| P / Tangible Book | 0.3 | 0.0 | · | |
| P / Cash Flow | -0.6 | -0.0 | · | |
| P / FCF | -0.6 | -0.0 | · | |
| Earnings Yield | -216.7% | -132.8% | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $10M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | $13M | $10M | |
| SG&A Expense | $10M | $5M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $24M | $14M | $14M | $15M | $17M | $17M | $18M | $19M | $19M | $17M | $14M | |
| Operating Income | $-24M | $-14M | $-14M | $-15M | $-17M | $-17M | $-18M | $-19M | $-19M | $-17M | $-14M | |
| Interest Income | $690.0K | $920.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Other Non-op | $1.0K | · | $0 | $0 | $0 | $-2.0K | $-85.0K | $32.0K | $33.0K | $32.0K | $64.0K | |
| Net Income | $-24M | $-14M | $-13M | $-14M | $-16M | $-16M | $-16M | $-17M | $-17M | $-15M | $-12M | |
| EPS (Basic) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| EPS (Diluted) | $-1.06 | $-0.60 | $-0.57 | $-0.62 | $-0.70 | $-0.71 | $9.93 | $-0.74 | $-0.77 | $-12.27 | $-9.75 | |
| Shares (Basic) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| Shares (Diluted) | 22,450,000 | 22,407,000 | -44,682,000 | 22,386,000 | 22,356,000 | 22,300,000 | -28,551,000 | 22,254,000 | 22,023,000 | 1,258,000 | -2,403,000 | |
| EBITDA | $-24M | $-14M | · | $-15M | $-17M | $-17M | · | $-19M | $-19M | $-17M | · |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $17M | $18M | $15M | $15M | $15M | $27M | $40M | $31M | $25M | $24M | |
| Short-term Investments | $52M | $75M | $90M | $103M | $112M | $123M | $126M | $127M | $148M | $80M | $97M | |
| Prepaid Expense | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $4M | $7M | $3M | |
| Current Assets | $74M | $95M | $110M | $120M | $130M | $140M | $154M | $170M | $183M | $112M | $124M | |
| PP&E (Net) | $97.0K | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $2M | $3M | |
| PP&E (Gross) | $4M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $5M | $5M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Total Assets | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $2M | $1M | $1M | $3M | $2M | $3M | $2M | |
| Current Liabilities | $8M | $10M | $13M | $12M | $9M | $6M | $8M | $10M | $9M | $11M | $9M | |
| Capital Leases | $0 | $45M | $46M | $47M | $48M | $48M | $48M | · | · | · | · | |
| Total Liabilities | $8M | $55M | $58M | $59M | $57M | $55M | $56M | · | · | · | $9M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 | |
| Paid-in Capital | $363M | $360M | $358M | $357M | $356M | $354M | $352M | $350M | $348M | $10M | $9M | |
| Retained Earnings | $-297M | $-273M | $-260M | $-247M | $-233M | $-217M | $-201M | $-185M | $-169M | $-152M | $-136M | |
| AOCI | $-32.0K | $-23.0K | $64.0K | $50.0K | $-4.0K | $32.0K | $121.0K | $236.0K | $-64.0K | $-21.0K | $40.0K | |
| Stockholders' Equity | $66M | $86M | $99M | $110M | $123M | $137M | $151M | $165M | $179M | $-141M | $-127M | |
| Liabilities + Equity | $74M | $141M | $157M | $169M | $179M | $191M | $206M | $175M | $188M | $117M | $130M | |
| Shares Outstanding | 22,475,000 | 22,407,000 | 22,407,000 | 22,386,000 | 22,386,000 | 22,300,000 | 22,300,000 | 22,254,465 | 22,254,102 | 1,262,638 | 1,248 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $284.0K | $307.0K | $310.0K | $317.0K | $317.0K | $296.0K | $262.0K | $265.0K | $263.0K | $247.0K | |
| Stock-based Comp | $3M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $911.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-886.0K | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-15M | $-10M | $-10M | $-12M | $-15M | $-16M | $-13M | $-16M | $-16M | $-12M | |
| CapEx | $38.0K | $8.0K | $424.0K | $15.0K | $48.0K | $59.0K | $466.0K | $483.0K | $2M | $83.0K | $268.0K | |
| Investing Cash Flow | $23M | $15M | $13M | $10M | $11M | $3M | $2M | $22M | $-68M | $18M | $16M | |
| Financing Cash Flow | · | · | $24.0K | $0 | · | · | $113.0K | $-13.0K | $91M | $-924.0K | $-1M | |
| Net Change in Cash | $2M | $-385.0K | $3M | $283.0K | $-420.0K | $-11M | $-14M | $9M | $6M | $1M | $3M | |
| Free Cash Flow | · | $-15M | · | · | · | $-15M | · | · | · | $-16M | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.7% | -8.2% | · | -8.1% | -8.5% | -10.2% | · | -18.9% | -18.0% | -26.4% | · | |
| ROE | -25.1% | -12.2% | · | -10.1% | -10.4% | 686.3% | · | -20.0% | -18.9% | 21.9% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.5 | 9.9 | · | 10.1 | 14.1 | 22.1 | · | 17.0 | 20.4 | 10.5 | · | |
| Quick Ratio | 9.3 | 9.7 | · | 9.9 | 13.8 | 21.8 | · | 16.7 | 20.0 | 9.9 | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-67M | $-59M | · | $-62M | $-65M | $-65M | · | $-62M | $-58M | $-53M | · | |
| Market Cap | $56M | $25M | · | $28M | $23M | $34M | · | $77M | $86M | $18M | · | |
| P/E | -0.8 | -0.4 | · | -0.4 | -0.3 | -0.1 | · | -0.1 | -0.1 | -0.3 | · | |
| P/B | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | -0.1 | · | |
| P / Tangible Book | 0.9 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.5 | · | · | |
| P / Cash Flow | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| P / FCF | · | -1.6 | · | · | · | -2.3 | · | · | · | -1.1 | · | |
| Earnings Yield | -119.2% | -239.1% | · | -225.2% | -289.1% | -959.6% | · | -705.8% | -879.3% | -302.9% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Beneficio neto | $-58M | $-65M | $-49M |
| EPS Diluido | $-2.60 | $-3.85 | $-40.65 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 8.7 | 19.0 | — |
| Ratio Rápido | 8.6 | 18.7 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-47M | $-63M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 45 declarantes · $37.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 16 (+12 vs trimestre anterior) | 7 (+1 vs trimestre anterior) | 8 (+2 vs trimestre anterior) | 10 (+2 vs trimestre anterior) | +8.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $6 735 238 | 2 694 095 | 17,91% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $6 399 688 | 2 559 875 | 17,02% | Acciones |
| ADAR1 Capital Management, LLC | $4 920 540 | 1 968 216 | 13,08% | Acciones |
| Nextech Invest Ltd. | $3 561 400 | 1 228 069 | 9,47% | Acciones |
| FMR LLC | $3 332 450 | 1 332 980 | 8,86% | Acciones |
| Cormorant Asset Management, LP | $2 500 000 | 1 000 000 | 6,65% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 537 308 | 614 923 | 4,09% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 390 583 | 556 233 | 3,70% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 196 598 | 478 639 | 3,18% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 178 925 | 471 570 | 3,13% | Acciones |
| Alyeska Investment Group, L.P. | $750 000 | 300 000 | 1,99% | Acciones |
| Affinity Asset Advisors, LLC | $625 000 | 250 000 | 1,66% | Acciones |
| RBF Capital, LLC | $500 000 | 200 000 | 1,33% | Acciones |
| Ensign Peak Advisors, Inc | $399 588 | 159 835 | 1,06% | Acciones |
| Stonepine Capital Management, LLC | $386 488 | 154 595 | 1,03% | Acciones |
| CITADEL ADVISORS LLC | $362 623 | 145 049 | 0,96% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $320 000 | 128 000 | 0,85% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $240 132 | 96 053 | 0,64% | Acciones |
| PRELUDE CAPITAL MANAGEMENT, LLC | $209 995 | 83 998 | 0,56% | Acciones |
| Rangeley Capital, LLC | $185 000 | 74 000 | 0,49% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $162 840 | 65 136 | 0,43% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $138 390 | 55 356 | 0,37% | Acciones |
| JANE STREET GROUP, LLC | $114 675 | 45 870 | 0,30% | Acciones |
| NORTHERN TRUST CORP | $87 060 | 34 824 | 0,23% | Acciones |
| XTX Topco Ltd | $83 403 | 33 361 | 0,22% | Acciones |
| Nuveen Asset Management, LLC | $62 417 | 21 523 | 0,17% | Acciones |
| Qube Research & Technologies Ltd | $50 518 | 20 207 | 0,13% | Acciones |
| China Universal Asset Management Co., Ltd. | $42 250 | 16 900 | 0,11% | Acciones |
| STATE STREET CORP | $39 905 | 15 962 | 0,11% | Acciones |
| MORGAN STANLEY | $32 500 | 13 000 | 0,09% | Acciones |
| Caitong International Asset Management Co., Ltd | $26 108 | 10 443 | 0,07% | Acciones |
| Pure Financial Advisors, LLC | $25 250 | 10 100 | 0,07% | Acciones |
| BlackRock, Inc. | $10 223 | 4 089 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $870 | 348 | 0,00% | Acciones |
| VANGUARD GROUP INC | $515 | 429 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $440 | 176 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $365 | 146 757 | 0,00% | Acciones |
| HRT FINANCIAL LP | $290 | 116 288 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $181 | 72 353 | 0,00% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $125 | 50 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $25 | 10 | 0,00% | Acciones |
| CWM, LLC | $9 | 8 | 0,00% | Acciones |
| Financial Management Professionals, Inc. | $5 | 2 | 0,00% | Acciones |
| UBS Group AG | $5 | 2 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $5 | 2 | 0,00% | Acciones |
Informantes de la empresa 14 insiders · 8 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Zachary Hornby | President & CEO | 23 de enero de 2026 A | — | 0 | 0 | $0 |
| Jami Rubin | Chief Financial Officer | 19 de agosto de 2024 A | — | 0 | 0 | $0 |
| Robert Doebele | Chief Medical Officer | 23 de enero de 2026 A | — | 0 | 0 | $0 |
| Jessica Oien | Chief Legal Officer and Corporate Secretary | 23 de enero de 2026 A | — | 0 | 0 | $0 |
| Christian Hassig | Chief Scientific Officer | 23 de enero de 2026 A | — | 0 | 0 | $0 |
| David A Hinkle | Senior VP, Finance, Controller and Treasurer | 23 de enero de 2026 A | — | 0 | 0 | $0 |
| Klaus W. Wagner | Chief Medical Officer | 19 de agosto de 2024 A | — | 0 | 0 | $0 |
| Neil Abdollahian | Chief Business Officer | 19 de agosto de 2024 A | — | 0 | 0 | $0 |
| James Christensen | Consejero | 15 de junio de 2026 A | — | 0 | 0 | $0 |
| Nancy Whiting | Consejero | 15 de junio de 2026 A | — | 0 | 0 | $0 |
| Jennifer Lew | Consejero | 15 de junio de 2026 A | — | 0 | 0 | $0 |
| Jonathan E Lim | Consejero | 15 de junio de 2026 A | 550 915 | 0 | 0 | $0 |
| Christine Brennan | Consejero | 23 de junio de 2025 A | — | 0 | 0 | $0 |
| Kristina Burow | Consejero | 23 de junio de 2025 A | 1 181 766 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund X Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners X Overage, L.P., ARCH Venture Partners IX, LLC, ARCH Venture Partners X, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee, Kristina Burow, Steven Gillis | 29 de octubre de 2024 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 3 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.